Khalil Ahmed

Khalil Ahmed is a Professor at the University of Minnesota, specializing in cellular mechanisms of cancer and protein kinase CK2 research. His work spans prostate, breast, and head and neck cancers, with a focus on therapeutic development and molecular biology.

His recent projects include NIH-funded studies on CK2 inhibitors and collaborations with Dr. James H. Trembley, Dr. B. T. Kren, and others. Grants from the Higher Education Commission Pakistan supported visiting scholars in his lab.

• 2024: CK2 downregulation in oncomir clusters
• 2023: Comprehensive review of CK2 roles in cancer
• 2021: Cx-4945 and siRNA applications in HPV-related cancers

His research explores CK2's therapeutic potential, combining molecular biology with clinical outcomes, and addresses drug resistance in head and neck squamous cell carcinomas.